跳至主要内容
临床试验/DRKS00009995
DRKS00009995招募中不适用

on-interventional, prospective health services research study on the course of testosterone levels during androgen deprivation therapy (ADT) with LHRH analogues (3-month depot). - TestoVer-Study

d-uo | Deutsche Uro-Onkologen e.V.0 个研究点目标入组 1,000 人开始时间: 2021年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • 1. age >= 18 years
  • 2. written informed consent and consent for the processing of personal data are available.
  • 3. patients with advanced hormonal prostate carcinoma, in whom the indication for ADT exists and a corresponding drug treatment is planned independently of the participation in this study.

排除标准

  • 1. bilateral orchiectomy
  • 2. hypersensitivity to LHRH analogues according to the respective technical information
  • 3. previous hormone therapy

研究者

发起方
d-uo | Deutsche Uro-Onkologen e.V.

相似试验